Published in Health and Medicine Week, January 19th, 2004
Pronova Biocare develops, produces and sells marine omega-3 fatty acids. There are three equal business areas: drugs, consumer brands and industry sales. Pronova Biocare has production facilities at Sandefjord and Alesund, Norway, main markets are the European Union and the U.S. The company has developed Omacor, the first drug entirely developed in Norway. It is based on omega-3 and holds approval in several European countries for medical treatment of myocardial infarction and other cardiovascular diseases.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week